← Evidence map

ArticleDermatology (Basel, Switzerland)2025

ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa.

Mercè Grau-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. | OpenQuestion